The Novel HSF1 Inhibitor NXP800 Exhibits Robust Antitumor Activity in Hepatocellular Carcinoma
Sara Steinmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Diego F. Calvisi(University of Regensburg)
Cited by 0
Related Papers
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
|Gastroenterology|2006|726
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
|Journal of Clinical Investigation|2007|395
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
|Scientific Reports|2016|124
DAPK1 loss triggers tumor invasion in colorectal tumor cells
|Cell Death and Disease|2019|78
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
|Nature Communications|2023|76